U.S. FDA expands approval of Roche hemophilia drug

Roche on Thursday said U.S. regulators approved expanded use of its drug Hemlibra to include almost all patients with hemophilia A, as the Swiss drugmaker increases its focus on diseases beyond cancer to help replace revenue from older products that have lost patent protection.

from Reuters: Health https://ift.tt/2xZ863S
via IFTTT

• Tweet
• Share
• Share
• Share
• Share